Download PDF
Thromb Haemost 2005; 93(06): 1153-1160
DOI: 10.1160/TH04-12-0782
Wound Healing and Inflammation/Infection
Schattauer GmbH

Relationship between peripheral arterial occlusive disease (PAOD) and chronic Chlamydophila (Chlamydia) pneumoniae infection

A meta-analysis
José Gutiérrez
1   Department of Microbiology, University of Granada, Granada, Spain
,
Juan de Dios Luna
2   Department of Statistics, University of Granada, Granada, Spain
,
José Linares
3   Department of Surgery, University of Granada, Granada, Spain
,
María del Rosario Montes
1   Department of Microbiology, University of Granada, Granada, Spain
,
Emilia Quesada
1   Department of Microbiology, University of Granada, Granada, Spain
,
Almudena Rojas
4   Laboratorio Vircell, Granada, Spain
,
María José Soto
1   Department of Microbiology, University of Granada, Granada, Spain
,
Antonio Sorlozano
1   Department of Microbiology, University of Granada, Granada, Spain
› Author AffiliationsGrant support: This study was funded in part by grants from the Innovation, Science and Technology Department of the Regional Government of Andalusia (Research group CTS 521 for the study of infectious agents related to clinical processes of unknown cause), the University of Granada (Project for the detection of Chlamydophila pneumoniae in peripheral arterial disease- the role of the leukocyte), Vitro S. A., and Laboratoires Abbot-Pensa.
Further Information

Publication History

Received 07 December 2004

Accepted after resubmission 03 March 2005

Publication Date:
11 December 2017 (online)

    Permissions and Reprints

Summary

We carried out a meta-analysis of observational case-control studies published before May 2004 to assess the degree of association between Chlamydophila pneumoniae (Cp) infection and PAOD. A search of the Medline database was performed using atherosclerosis and "Chlamyd* pneumoniae" as keywords. Strict criteria were applied for the selection of case studies, which had to be studies of Cp seroprevalence or of Cp detection in patients versus controls. Forty-three published studies that met these criteria were selected. An association between PAOD and Cp was revealed by immunohistochemical analysis (OR=15.4, 95%CI=5.0–46.9) and nested PCR studies of arterial biopsies (OR=4.3, 95%CI=1.8–10), by PCR study of non-arterial samples (OR=2.9, 95%CI=1.2–7.0), by other direct-detection tests (OR=16.7, 95%CI=7.0–39.8), and by ELISA and MIF tests to detect high IgG (OR=2, 95%CI=1.1–3.5 and OR=1.7, 95%CI=1.0–2.9, respectively) and IgA (OR=1.9, 95%CI=1.1–3.4 and OR=1.5, 95%CI=1.1–2.0, respectively) titers. No significant association was found in simple PCR studies of arterial biopsies, MIF tests to detect low IgG titers or IgM, or ELISA studies to detect IgM. According to this review, the association between Cp infection and PAOD depends on the analytical method adopted. Establishing a relationship between Cp and PAOD will require a case-control study with an adequate number of cases and samples that uses a combination of direct and indirect techniques to identify the presence of the bacterium in different types of sample from the same subjects, correlating the results with the activity of the disease.

Keywords

Bacteria - atherosclerosis - clinical / epidemiological studies
 

  • References

  • 1 Ross R. Atherosclerosis–an inflammatory disease. New Engl J Med 1999; 340: 115-26
    CrossrefPubMedGoogle Scholar
  • 2 Lindsberg PJ, Grau AJ. Inflammation and infections as risk factors for ischemic stroke. Stroke 2003; 34: 2518-32
    CrossrefPubMedGoogle Scholar
  • 3 Cook PJ, Honeybourne D, Lip GY. et al Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. Stroke 1998; 29: 404-10
    CrossrefPubMedGoogle Scholar
  • 4 Alakärppä H, Surcel H-M, Laitinen K. et al Detection of Chlamydia pneumoniae by colorimetric in situ hybridization. APMIS 1999; 107: 451-4
    CrossrefPubMedGoogle Scholar
  • 5 Gieffers J, Füllgraf H, Jahn J. et al Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation 2001; 103: 351-6
    CrossrefPubMedGoogle Scholar
  • 6 Kutlin A, Roblin PM, Hammerschlag MR. Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection model antimicrobial agents and chemotherapy. Antimicrob Agents Chemother 2002; 46: 409-12
    CrossrefPubMedGoogle Scholar
  • 7 Gutiérrez J, Linares JP, Rodríguez M. et al Chlamydia pneumoniae y su relación con la aterosclerosis humana. Rev Invest Clin 2000; 52: 482-6
    PubMedGoogle Scholar
  • 8 Kothe H, Dalhoff K, Rupp J. et al Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae. Circulation 2000; 101: 1760-3
    CrossrefPubMedGoogle Scholar
  • 9 Bloemenkamp DG, Mali WP, Visseren FL. et al Meta-analysis of seroepidemiologic studies of the relation between Chlamydia pneumoniae and atherosclerosis: does study design influence results?. Am Heart J 2003; 145: 409-17
    CrossrefPubMedGoogle Scholar
  • 10 Al-Amro AA, Al-Jafari AA, Al-Fagih MR. et al Frequency of occurrence of cytomegalovirus and Chlamydia pneumoniae in lymphocytes of atherosclerotic patients. Cent Eur J Public Health 2001; 9: 106-8
    PubMedGoogle Scholar
  • 11 Berger M, Schroder B, Daeschlein G. et al Chlamydia pneumoniae DNA in non-coronary atherosclerotic plaques and circulating leukocytes. J Lab Clin Med 2000; 136: 194-200
    CrossrefPubMedGoogle Scholar
  • 12 Chiu B, Viira E, Tucker W. et al Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 1997; 96: 2144-8
    CrossrefPubMedGoogle Scholar
  • 13 Elkind MS, Lin IF, Grayston JT. et al Chlamydia pneumoniae and the risk of first ischemic stroke: The Northern Manhattan Stroke Study. Stroke 2000; 31: 1521-5
    CrossrefPubMedGoogle Scholar
  • 14 Farsak B, Yildirir A, Akyon Y. et al Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J Clin Microbiol 2000; 38: 4408-11
    PubMedGoogle Scholar
  • 15 Freidank HM, Lux A, Dern P. et al Chlamydia pneumoniae DNA in peripheral venous blood samples from patients with carotid artery stenosis. Eur J Clin Microbiol Infect Dis 2002; 21: 60-2
    CrossrefPubMedGoogle Scholar
  • 16 Gil-Madre J, Garcia JL, Gonzalez RC. et al Association between seropositivity to Chlamydia pneumoniae and acute ischaemic stroke. Eur J Neurol 2002; 9: 303-6
    CrossrefPubMedGoogle Scholar
  • 17 Glader C, Stegmayr B, Boman J. et al Chlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarctions. Results from Case-Control study in Northern Sweden. Stroke 1999; 30: 2013-8
    CrossrefPubMedGoogle Scholar
  • 18 Goo Y, Moon H, Myung J. et al Serologic and histopathologic study of Chlamydia pneumoniae infection in atherosclerosis induced by Chlamydia pneumoniae. Yonsei Med J 2000; 41: 319-27
    CrossrefPubMedGoogle Scholar
  • 19 Gutiérrez J, Linares-Palomino J, López-Espada C. et al Chlamydia pneumoniae DNA in the arterial wall of patients with peripheral vascular disease. Infection 2001; 29: 196-200
    CrossrefPubMedGoogle Scholar
  • 20 Gutiérrez-Fernández J, Linares-Palomino J, Fernández- Sánchez F. et al The presence of anti-Chlamydia pneumoniae antibodies in peripheral vascular and neurological disorders. Rev Neurol 2001; 32: 501-5
    PubMedGoogle Scholar
  • 21 Juvonen J, Juvonen T, Laurila A. et al Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J Vasc Surg 1997; 25: 499-505
    CrossrefPubMedGoogle Scholar
  • 22 Kalayoglu MV, Galvan C, Mahdi OS. et al Serological association between Chlamydia pneumoniae infection and age-related macular degeneration. Arch Ophthalmol 2003; 121: 478-82
    CrossrefPubMedGoogle Scholar
  • 23 Kol A, Sukhova GK, Lichtman AH. et al Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 1998; 98: 300-7
    CrossrefPubMedGoogle Scholar
  • 24 Kuo CC, Gown AM, Benditt EP. et al Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb 1993; 13: 1501-4
    CrossrefPubMedGoogle Scholar
  • 25 LaBiche R, Koziol D, Quinn TC. et al Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque. Stroke 2001; 32: 855-60
    CrossrefPubMedGoogle Scholar
  • 26 Lehto S, Niskanen L, Suhonen M. et al Association between Chlamydia pneumoniae antibodies and intimal calcification in femoral arteries of nondiabetic patients. Arch Intern Med 2002; 162: 594-9
    CrossrefPubMedGoogle Scholar
  • 27 Lin TM, Chen WJ, Chen HY. et al Increased incidence of cytomegalovirus but not Chlamydia pneumoniae in atherosclerotic lesions of arteries of lower extremities from patients with diabetes mellitus undergoing amputation. J Clin Pathol 2003; 56: 429-32
    CrossrefPubMedGoogle Scholar
  • 28 Linares-Palomino J, Gutiérrez J, López-Espada C. et al Chlamydia pneumoniae and cerebrovascular disease. Rev Neurol 2001; 32: 201-6
    PubMedGoogle Scholar
  • 29 Maass M, Bartels C, Kruger S. et al Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease. Atherosclerosis 1998; 140 (Suppl. 01) S25-30
    CrossrefPubMedGoogle Scholar
  • 30 Maeda N, Sawayama Y, Tatsukawa M. et al Carotid artery lesions and atherosclerotic risk factors in Japanese hemodialysis patients. Atherosclerosis 2003; 169: 183-92
    CrossrefPubMedGoogle Scholar
  • 31 Melnick SL, Shahar E, Folsom AR. et al Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Med 1993; 95: 499-504
    CrossrefPubMedGoogle Scholar
  • 32 Müller J, Möller DS, Kjaer M. et al Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in healthy control subjects and patients with diabetes mellitus, acute coronary syndrome, stroke, and arterial hypertension. Scand J Infect Dis 2003; 35: 704-12
    CrossrefPubMedGoogle Scholar
  • 33 Neureiter D, Heuschmann P, Stintzing S. et al Detection of Chlamydia pneumoniae but not of Helicobacter Helicobacter pylori in symptomatic atherosclerotic carotids associated with enhanced serum antibodies, inflammation and apoptosis rate. Atherosclerosis 2003; 168: 153-62
    CrossrefPubMedGoogle Scholar
  • 34 Ong G, Thomas BJ, Mansfield AO. et al Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol 1996; 49: 102-6
    CrossrefPubMedGoogle Scholar
  • 35 Ong GM, Coyle PV, Barros D'Sa AA. et al Non-detection of Chlamydia species in carotid atheroma using generic primers by nested PCR in a population with a high prevalence of Chlamydia pneumoniae antibody. BMC Infect Dis 2001; 1: 12 Epub 24 August 2001.
    CrossrefPubMedGoogle Scholar
  • 36 Ouchi K, Fujii B, Kudo S. et al Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic tissue. J Infect Dis 2000; 181 (Suppl. 03) S441-3.
    CrossrefPubMedGoogle Scholar
  • 37 Ramos PM, Ortega F, Samaniego J. et al Microscopía electrónica, Chlamydia pneumoniae y arteriosclerosis. Med Clin (Barc) 1999; 112: 277-8
    PubMedGoogle Scholar
  • 38 Rassu M, Cazzavillan S, Scagnelli M. et al Demonstration of Chlamydia pneumoniae in atherosclerotic arteries from various vascular regions. Atherosclerosis 2001; 158: 73-9
    CrossrefPubMedGoogle Scholar
  • 39 Rose AG. Failure to detect Chlamydia pneumoniae in senile calcific aortic stenosis or calcified congenital bicuspid aortic valve by immunofluorescence, polymerase chain reaction and electron microscopy. Cardiovasc Pathol 2002; 11: 300-4
    CrossrefPubMedGoogle Scholar
  • 40 Sessa R, Di Pietro M, Schiavoni G. et al Chlamydia pneumoniae DNA in patients with symptomatic carotid atherosclerotic disease. J Vasc Surg 2003; 37: 1027-31
    CrossrefPubMedGoogle Scholar
  • 41 Shi Y, Tokunaga O. Chlamydia pneumoniae and multiple infections in the aorta contribute to atherosclerosis. Pathol Int 2002; 52: 755-63
    CrossrefPubMedGoogle Scholar
  • 42 Tanne D, Haim M, Boyko V. et al Prospective study of Chlamydia pneumoniae IgG and IgA seropositivity and risk of incident ischemic stroke. Cerebrovasc Dis 2003; 16: 166-70
    CrossrefPubMedGoogle Scholar
  • 43 Tarnacka B, Gromadzka G, Czlonkwska A. Increased circulating immune complexes in acute stroke. The Triggering role of Chlamydia pneumoniae and cytomegalovirus. Stroke 2002; 33: 936-40
    CrossrefPubMedGoogle Scholar
  • 44 Taylor-Robinson D, Thomas BJ, Goldin R. et al Chlamydia pneumoniae in infrequently examined blood vessels. J Clin Pathol 2002; 55: 218-20
    CrossrefPubMedGoogle Scholar
  • 45 van der Ven AJ, Hommels MJ, Kroon AA. et al Chlamydia pneumoniae seropositivity and systemic and renovascular atherosclerotic disease. Arch Intern Med 2002; 162: 786-90
    CrossrefPubMedGoogle Scholar
  • 46 Vécsei PV, Kircher K, Reitner A. et al Chlamydia pneumoniae in central retinal artery occlusion. Acta Ophthalmol Scand 2002; 80: 656-9
    CrossrefPubMedGoogle Scholar
  • 47 Vécsei PV, Kircher K, Reitner A. et al Chlamydia in anterior ischemic optic neuropathy. Ophthalmologica 2002; 216: 215-20
    CrossrefPubMedGoogle Scholar
  • 48 Virok D, Kis Z, Karai L. et al Chlamydia pneumoniae in atherosclerotic middle cerebral artery. Stroke 2001; 32: 1973-6
    CrossrefPubMedGoogle Scholar
  • 49 Wimmer ML, Sandmann-Strupp R, Saikku P. et al Association of chlamydial infection with cerebrovascular disease. Stroke 1996; 27: 2207-10
    CrossrefPubMedGoogle Scholar
  • 50 Wolf SC, Mayer O, Jurgens S. et al Chlamydia pneumoniae IgA seropositivity is associated with increased risk for atherosclerotic vascular disease, myocardial infarction and stroke in dialysis patients. Clin Nephrol 2003; 59: 273-9
    CrossrefPubMedGoogle Scholar
  • 51 Dersimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88
    CrossrefPubMedGoogle Scholar
  • 52 Rosenthal R. (1991). Meta-analytic procedures for social research. Newbury Park: CA, Sage;
    Google Scholar
  • 53 Egger M, Smith GP, Altman DG. Systematic reviews in health care. Meta-analysis context. BMJ Bookshop; London: 1995
    Google Scholar
  • 54 Weels G, Shea B, O´Connell D. et al The Newcastle- Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www. cochranemsk.org/review/resources/default. asp?s=1 Epub 1 June 2004.
    PubMedGoogle Scholar
  • 55 Danesh J, Whincup P, Walker M. et al Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. Br Med J 2000; 321: 208-13
    CrossrefPubMedGoogle Scholar
  • 56 Danesh J, Whincup P, Walker M. et al Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. Br Med J 2000; 321: 199-204
    CrossrefPubMedGoogle Scholar
  • 57 Danesh J, Whincup P, Lewington S. et al Chlamydia pneumoniae IgA titres and coronary heart disease: prospective study and meta-analysis. Eur Heart J 2002; 23: 371-5
    CrossrefPubMedGoogle Scholar
  • 58 Fowkes FG, Housley E, Riemersma RA. et al Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol 1992; 135: 331-40
    CrossrefPubMedGoogle Scholar
  • 59 Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237-8
    CrossrefPubMedGoogle Scholar
  • 60 Rupp J, Koch M, van Zandbergen G. et al Transmission of Chlamydia pneumoniae infection from blood monocytes to vascular cells in a novel transendothelial migration model. FEMS Microbiol Let 2005; 242: 203-8
    CrossrefPubMedGoogle Scholar
  • 61 Boman J, Hammerschlag MR. Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies. Clin Microbiol Rev 2002; 15: 1-20
    CrossrefPubMedGoogle Scholar
  • 62 Mandell GL, Bennett JE, Dolin R. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 6th Ed. Churchill Livingstone; 2004
    Google Scholar